Our data suggest that miR-433 can induce senescence independently from the canonical senescence program mediated by p53 and p21 and, more importantly, can sustain and amplify senescence initiated through the doxorubicin treatment of MM cells. Here, TP53 is linked to Miyoshi myopathy.